Skip to Content

AB International Strat Eqs Adv STEYX

Medalist Rating as of | See AllianceBernstein Investment Hub
  • NAV / 1-Day Return 12.67  /  −0.16 %
  • Total Assets 7.8 Bil
  • Adj. Expense Ratio
    0.710%
  • Expense Ratio 0.710%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 10,000
  • Status Closed
  • TTM Yield 2.76%
  • Turnover 92%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:23 PM GMT+0

Morningstar’s Analysis STEYX

Will STEYX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in AB International Strat Eqs Adv's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings STEYX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 29.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

4.84 374.0 Mil
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd

3.55 274.4 Mil
Technology

Wolters Kluwer NV

3.46 267.3 Mil
Industrials

Lvmh Moet Hennessy Louis Vuitton SE

2.67 206.4 Mil
Consumer Cyclical

GSK PLC

2.63 203.5 Mil
Healthcare

CRH PLC

2.59 200.3 Mil
Basic Materials

RELX PLC

2.58 199.5 Mil
Industrials

Industria De Diseno Textil SA Share From Split

2.47 190.6 Mil
Consumer Cyclical

Banco Bilbao Vizcaya Argentaria SA

2.44 188.6 Mil
Financial Services

Samsung Electronics Co Ltd

2.32 179.6 Mil
Technology